4//SEC Filing
Betz Stephen F. 4
Accession 0000950170-24-137923
CIK 0001658247other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:30 PM ET
Size
6.8 KB
Accession
0000950170-24-137923
Insider Transaction Report
Form 4
Betz Stephen F.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-12-16−2,331→ 180,039 totalExercise: $1.91Exp: 2028-03-16→ Common Stock (2,331 underlying) - Exercise/Conversion
Common Stock
2024-12-16$1.91/sh+2,331$4,452→ 71,358 total
Footnotes (1)
- [F1]1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001886575
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:30 PM ET
- Size
- 6.8 KB